Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...
In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...
A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings. The new ...
Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.
Market Report by Application, Distribution Channel, Route of Administration and Company Analysis, 2025-2033" has been added ...
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with ...
SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...
Jan. 5, 2026 CO2 can stimulate plant growth, but only when enough nitrogen is available—and that key ingredient has been seriously miscalculated. A new study finds that natural nitrogen fixation has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback